Doctor profile · Federal record
Dr. Salvatore Napoli, M.D.
Neurology Physician (CMS: Neurology) · Foxboro, MA
- NPI 1588715882
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 27 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
9 Payson RD Ste 100
Foxboro, MA 020351309
(781) 551-5812
fax (508) 698-8671
Credentials & registration
- NPI registered
- January 2007 — 19 yrs on file
- Profile last updated
- February 12, 2020
- Year of graduation
- 1999 — 27 yrs since
- Specialty taxonomy
- 2084N0400X — NUCC code
- State license (1)
- Massachusetts #223372
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1588715882. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
85,336
Distinct HCPCS
10
Medicare allowed
$2,947,150
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2350 |
Injection, ocrelizumab, 1 mg | 33,604 | 41 | $50 | |
J0585 |
Injection, onabotulinumtoxina, 1 unit | 23,619 | 44 | $6 | |
J2323 |
Injection, natalizumab, 1 mg | 19,263 | 13 | $22 | |
J3032 |
Injection, eptinezumab-jjmr, 1 mg | 3,313 | 11 | $17 | |
J3245 |
Injection, tildrakizumab, 1 mg | 2,804 | 11 | $138 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 362 | 219 | $191 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 356 | 196 | $138 | |
J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg | 307 | 54 | $5 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 295 | 81 | $148 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 215 | 52 | $29 |
In context: peer comparison
Among 1 peers in Foxboro Neurology Physician, average services per provider: 3,413. This provider delivers 25× the peer median.Open Payments
Industry payments received
All-time total
$86,186
Transactions
171
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Tg Therapeutics, INC. | 10 | $17,439.93 | |
| Emd Serono, INC. | 34 | $16,121.39 | |
| Eisai INC. | 20 | $13,755.85 | |
| Biogen, INC. | 16 | $13,725.66 | |
| Mallinckrodt Hospital Products INC. | 9 | $9,185.47 | |
| Merck Sharp & Dohme LLC | 1 | $4,185.00 | |
| Genzyme Corporation | 3 | $3,658.21 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $2,961.02 | |
| Ani Pharmaceuticals, INC. | 5 | $2,449.58 | |
| Lundbeck LLC | 16 | $504.41 | |
| ModernaTX, INC. | 1 | $500.00 | |
| Sk Life Science, INC. | 13 | $400.51 | |
| Celgene Corporation | 9 | $393.23 | |
| Amgen INC. | 18 | $252.51 | |
| Pfizer INC. | 13 | $138.11 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,582
Patients
280
Total drug cost
$4,066,399
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Gabapentin | Generic | 319 | 68 | $12,183 |
| Dalfampridine ER (Dalfampridine) | Brand | 318 | 47 | $185,745 |
| Baclofen | Generic | 268 | 82 | $10,878 |
| Kesimpta Pen (Ofatumumab) | Brand | 105 | 16 | $1,183,872 |
| Copaxone (Glatiramer Acetate) | Brand | 96 | 0 | $652,460 |
| Tysabri (Natalizumab) | Brand | 75 | 11 | $659,801 |
| Aubagio (Teriflunomide) | Brand | 68 | 13 | $782,352 |
| Tizanidine Hcl | Generic | 53 | 18 | $1,048 |
| Clonazepam | Generic | 46 | 0 | $360 |
| Ampyra (Dalfampridine) | Brand | 44 | 0 | $270,153 |
Frequently asked questions
What is Dr. Salvatore Napoli's medical specialty?
Dr. Salvatore Napoli practices Neurology Physician in Foxboro, MA.
Where does Dr. Salvatore Napoli practice?
Dr. Salvatore Napoli practices at 9 Payson RD Ste 100, Foxboro, MA 020351309. Office phone: 7815515812.
What is Dr. Salvatore Napoli's NPI?
Dr. Salvatore Napoli's National Provider Identifier (NPI) is 1588715882, issued by NPPES.
Does Dr. Salvatore Napoli accept Medicare assignment?
Yes. Dr. Salvatore Napoli accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Salvatore Napoli commonly perform?
Top Medicare-reported procedures in 2023: Injection, ocrelizumab, 1 mg (HCPCS J2350); Injection, onabotulinumtoxina, 1 unit (HCPCS J0585); Injection, natalizumab, 1 mg (HCPCS J2323). Source: CMS Medicare Physician & Other Practitioners file.